Last reviewed · How we verify
NCT04030910
'LIFEView' Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life
NA trial testing 'LIFEView' in Palliative Care in 38 participants. Completed in 31 December 2022.
31 December 2022
Quick facts
| Lead sponsor | Bruyère Health Research Institute. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 38 |
| Start date | 16 October 2019 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- 'LIFEView'
Conditions studied
- Palliative Care — all drugs for Palliative Care →
- Terminal Illness — all drugs for Terminal Illness →
- Quality of Life — all drugs for Quality of Life →
- Psychological Distress — all drugs for Psychological Distress →
Sponsor
Bruyère Health Research Institute.
Who can join
18 and older, any sex, with Palliative Care or Terminal Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is looking to assess the use of an audio-video technology called 'LIFEView' using a laptop and large-screen TV. This tool intends to support life review or reminiscence of past experiences, escape from current surroundings using virtual travel, or virtual visits to a location that one might have liked to visit in their lifetime but could not. We hope that by using this technology, we can support better wellbeing and quality of life for patients receiving palliative care services within the community and on an inpatient palliative care unit, or for patients at the end-of-life within Bruyère long-term care homes. Due to the potential for disorientation and reduced physical mobility, patients receiving palliative and end-of-life care may be unable to fully enjoy an immersive experience using a virtual reality (VR) headset. To reduce the possibility of disorientation that may arise from using a VR headset with 'LIFEView', our research team will use the 'LIFEView' prototype software loaded on a laptop and connected to a mobile high-definition 50" TV for inpatient PCU and LTC facility use, or to a patient's personal TV within their residence in the community. This setup will also improve accessibility to 'LIFEView' as a result of its relatively low-tech requirements (i.e. TV + laptop), and allows for an opportunity for patients and their loved ones to share cherished memories and stories.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04030910
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Palliative Care
Currently open trials in the same condition.
- NCT07505706 — Patient Journey in Palliative Care Within the NOVO Hospital Group. · active not recruiting
- NCT07469761 — MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care · NA · recruiting
- NCT06588556 — Improving Needs Among Older Adults · NA · recruiting
- NCT07109050 — Virtual Reality Within Palliative Care (VR-SPC) · NA · recruiting
- NCT06771999 — Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Phar · NA · recruiting
Other Bruyère Health Research Institute. trials
Trials by the same sponsor.
- NCT07248046 — Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study) · recruiting
- NCT07153341 — Evaluation of the STEP Intervention for Long-Term Care Residents Facing Hospital Transfer Decisions · NA · recruiting
- NCT07313657 — Improving Care and Mental Well-Being for Adults With Heart Failure · NA · recruiting
- NCT06953596 — Transcranial Magnetic Stimulation to Treat Prolonged Grief Disorder · NA · not yet recruiting
- NCT04824144 — Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04030910 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bruyère Health Research Institute.
- Last refreshed: 3 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04030910.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing